Cytosorbents Crp (CTSO)
Cytosorbents Crp (CTSO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -12 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.7 | -9.0 | -6.7 | -6.5 | -11 | -17 | -5.6 | -14 | -28 | -22 | -14 | -12 | |
| 0.1 | 0.1 | 0.2 | 0.2 | 0.4 | 0.6 | 0.7 | 1.1 | 1.1 | 2.0 | 1.8 | 1.0 | |
| 0.7 | 0.4 | 2.8 | 3.3 | 5.4 | 2.8 | 4.7 | 6.2 | 3.8 | 3.7 | 3.8 | 2.8 | |
| 3.4 | 0.8 | 3.6 | 2.6 | 6.8 | 3.3 | 2.0 | 8.8 | 7.0 | – | – | – | |
| -0.6 | -0.4 | 1.7 | -0.2 | -0.9 | -1.5 | -0.8 | 0.6 | -3.6 | 2.4 | -4.4 | -1.0 | |
| 0.4 | 0.6 | 0.6 | 1.7 | 1.5 | 1.5 | 1.7 | 4.3 | 6.5 | 0.9 | 0.3 | 0.2 | |
| -2.3 | -0.9 | 1.6 | -1.7 | -1.5 | -1.5 | -1.7 | -4.3 | -6.5 | -0.9 | -0.7 | -0.4 | |
| 0.0 | 0.0 | 0.0 | 0.3 | – | – | – | – | 5.0 | – | – | – | |
| 0.0 | 12 | 0.2 | 15 | 3.5 | 2.5 | 1.5 | -0.1 | 0.0 | – | – | – | |
| 5.0 | 5.0 | 5.0 | 5.0 | -0.1 | 5.0 | -15 | 5.0 | 5.0 | 0.0 | 10 | 2.5 | |
| 10 | 12 | 5.1 | 20 | 17 | 8.2 | 66 | 0.7 | 5.0 | 14 | 9.3 | 9.3 | |
| 1.4 | 1.7 | -0.1 | 12 | 5.0 | -10 | 59 | -18 | -30 | -8.2 | -5.9 | -2.0 | |
| -7.0 | -9.7 | -7.3 | -8.1 | -12 | -18 | -7.3 | -18 | -35 | -23 | -15 | -13 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.